Titre:
  • Benralizumab versus placebo for hypereosinophilic syndrome: a randomized, placebo-controlled phase 3 trial
Auteur:Ogbogu, Princess U; Roufosse, Florence; Akuthota, Praveen; Kuna, Piotr; Groh, Matthieu; Reiter, Andreas; Yokota, Akira; Siddiqui, Salman; Mutsaers, Pim P.G.N.J.; Li, Bing; Khoury, Paneez; Bahadori, Lila L.M.; Bednarczyk, Artur; Bouma, Gerben; Brooks, Laura; Ferreira, Jorge; Grindebacke, Hanna; Ho, Calvin C.N.; Jain, Priya; Palmer, Rebecca R.L.; Jison, Maria; Klion, Amy
Informations sur la publication:Nature medicine, 32, 6, page (2319)
Statut de publication:Publié, 2026-06
Sujet CREF:Généralités
Note générale:SCOPUS: ar.j
Langue:Anglais
Identificateurs:urn:issn:1078-8956
info:doi/10.1038/s41591-026-04315-8
info:scp/105035349939
info:pmid/41917160